16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal

Rachel Rosen1, Lan Hu2, Janine Amirault1

  • 1Aerodigestive Center, Division of Gastroenterology and Nutrition, Boston Children's Hospital, Boston, MA.

The Journal of Pediatrics
|February 10, 2015
PubMed

Insights

Proton pump inhibitor (PPI) use alters gut bacteria, potentially affecting lung and throat microbes through reflux. Gastric and lung bacteria showed closer relationships, suggesting aspiration of reflux contributes to these changes.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Pulmonology

Background:

  • Proton pump inhibitors (PPIs) are widely used medications.
  • Their impact on the human microbiome, particularly in the upper gastrointestinal and respiratory tracts, is an area of ongoing research.
  • Understanding these effects is crucial for evaluating potential side effects and optimizing treatment.

Purpose of the Study:

  • To investigate the hypothesis that proton pump inhibitor (PPI) use leads to alterations in gastric microflora.
  • To determine if these gastric microflora changes, via full column reflux, subsequently affect lung and oropharyngeal microflora.
  • To explore the relationship between PPI dosage and observed microflora changes.

Main Methods:

  • A prospective, cross-sectional cohort study involving 116 children with chronic cough.
  • Participants were divided into two groups: those on PPIs (n=59) and those not on PPIs (n=57).
  • Simultaneous bronchoscopy and upper endoscopy were performed, with 16S sequencing of gastric, bronchoalveolar lavage, and oropharyngeal fluids. Multichannel intraluminal impedance testing was conducted on 50 patients.

Main Results:

  • Increased abundance of Streptococcus in the gastric fluid of children on PPIs, correlating with PPI dosage.
  • Significant differences in oropharyngeal Streptococcus abundance were observed in PPI-treated patients.
  • Eight bacterial genera were found in gastric and lung fluids but not oropharyngeal, indicating site exchange. Lactococcus and Acinetobacter were more abundant with greater reflux, suggesting aspiration. Principal component analysis showed greater overlap between gastric and lung microflora compared to oropharyngeal.

Conclusions:

  • Proton pump inhibitor (PPI) use is associated with distinct changes in gastric, lung, and oropharyngeal microflora.
  • While microflora exchange occurs among these sites, gastric and lung microflora exhibit a closer relationship.
  • Aspiration of full column reflux is proposed as a potential mechanism for microflora exchange between the gastric and lung environments.
Abstract

Related Concept Videos

Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
65
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
45
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
240
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
59
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
79.7K
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
77